Key Details
Price
$6.86Last Dividend
$2.47Annual ROE
-11.22%Beta
1.05Events Calendar
Next earnings date:
May 09, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
July 15, 2021Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
07 Apr '20 Piper Sandler
Overweight11 Dec '19 PiperJaffray
Overweight11 Dec '19 Piper Sandler
Overweight14 June '19 Piper Sandler
Overweight14 June '19 Piper Jaffray
OverweightScreeners with XBIT included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
XBIT
globenewswire.com18 June 2024
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy
FAQ
- What is the primary business of XBiotech?
- What is the ticker symbol for XBiotech?
- Does XBiotech pay dividends?
- What sector is XBiotech in?
- What industry is XBiotech in?
- What country is XBiotech based in?
- When did XBiotech go public?
- Is XBiotech in the S&P 500?
- Is XBiotech in the NASDAQ 100?
- Is XBiotech in the Dow Jones?
- When was XBiotech's last earnings report?
- When does XBiotech report earnings?
- Should I buy XBiotech stock now?
What is the primary business of XBiotech?
XBiotech is a biotechnology company focused on developing innovative therapies for cancer and other diseases. They use a unique approach to create treatments based on human antibodies, aiming to improve patient outcomes and provide effective solutions in the field of medicine.
What is the ticker symbol for XBiotech?
The ticker symbol for XBiotech is NASDAQ:XBIT
Does XBiotech pay dividends?
No, XBiotech does not pay dividends
What sector is XBiotech in?
XBiotech is in the Healthcare sector
What industry is XBiotech in?
XBiotech is in the Biotechnology industry
What country is XBiotech based in?
XBiotech is headquartered in United States
When did XBiotech go public?
XBiotech's initial public offering (IPO) was on 15 April 2015
Is XBiotech in the S&P 500?
No, XBiotech is not included in the S&P 500 index
Is XBiotech in the NASDAQ 100?
No, XBiotech is not included in the NASDAQ 100 index
Is XBiotech in the Dow Jones?
No, XBiotech is not included in the Dow Jones index
When was XBiotech's last earnings report?
XBiotech's most recent earnings report was on 13 November 2024
When does XBiotech report earnings?
The next expected earnings date for XBiotech is 9 May 2025
Should I buy XBiotech stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions